Proceedings from the third in a 3-part webinar series. Featuring
perspectives from Drs Marcia S Brose, Andrew McKenzie and Milan
Radovich, including on the following topics:
Part 1: Molecular Tumor Board
Introduction (00:00)
Case: A woman in her late 70s with
ER-positive, HER2-negative metastatic breast cancer (ESR, CHEK2 and
RET mutations) — Sulfi Ibrahim, MD (6:09)
Case: A woman in her mid-40s with metastatic
thymoma (MTOR gain-of-function mutation) — Milan Radovich, PhD
(13:29)
Case: A patient with leiomyosarcoma (BRCA
germline mutation) — Andrew McKenzie, PhD (15:05)
Case: A patient with bone-only disease — Dr
Ibrahim (16:44)
Part 2: New Molecular Targets in Thyroid
Cancer
Case: A woman in her late 30s with
RAI-refractory papillary thyroid cancer — Marcia S Brose, MD, PhD
(21:25)
Case: A man in his late 60s with papillary
thyroid cancer — Dr Brose (29:25)
Case: A woman in her late teens with locally
advanced medullary thyroid cancer — Dr Brose (36:04)
Case: A frail woman in her late 70s with
metastatic papillary thyroid cancer (CAD) — Dr Ibrahim (39:46)
Case: A man in his late 50s with metastatic
thyroid cancer (RET M918T gain-of-function mutation) — Dr Radovich
(43:40)
Case: A man in his early 70s with metastatic
medullary thyroid cancer (RET mutation) — Dr McKenzie (46:27)
Part 3: Targeting the FGFR Signaling Pathway in
Cholangiocarcinoma
Case: A woman in her late 50s with metastatic
cholangiocarcinoma (FGFR2-BICC1 fusion) — Dr Radovich (48:28)
Part 4: New Options in the Management of GIST Harboring
PDGFR Mutations
Case: A patient with GIST (PDGFRA) — Dr
McKenzie (52:57)
Case: A woman in her early 60s with metastatic
GIST (gain-of-function PDGFRA D842Y mutation) — Dr Radovich
(54:23)
Part 5: Molecular Tumor Board (Continued)
Case: A man in his late 70s with metastatic
pancreatic cancer (EGFR exon 19 deletion) — Justin Peter Favaro,
MD, PhD (55:30)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.